Literature DB >> 31378813

Cohort Profile: The Right Drug, Right Dose, Right Time: Using Genomic Data to Individualize Treatment Protocol (RIGHT Protocol).

Suzette J Bielinski1, Jennifer L St Sauver1,2, Janet E Olson1,3, Nicholas B Larson4, John L Black3,5, Steven E Scherer6, Matthew E Bernard7, Eric Boerwinkle8, Bijan J Borah2,9, Pedro J Caraballo10, Timothy B Curry3,11, HarshaVardhan Doddapaneni12, Christine M Formea13, Robert R Freimuth14, Richard A Gibbs6, Jyothsna Giri3, Matthew A Hathcock4, Jianhong Hu12, Debra J Jacobson4, Leila A Jones3, Sara Kalla12, Tyler H Koep15, Viktoriya Korchina12, Christie L Kovar12, Sandra Lee12, Hongfang Liu14, Eric T Matey3,13, Michaela E McGree4, Tammy M McAllister3, Ann M Moyer5, Donna M Muzny12, Wayne T Nicholson11, Lance J Oyen13, Xiang Qin12, Ritika Raj12, Véronique L Roger1,16, Carolyn R Rohrer Vitek3, Jason L Ross15, Richard R Sharp3,9, Paul Y Takahashi17, Eric Venner12, Kimberly Walker12, Liwei Wang14, Qiaoyan Wang12, Jessica A Wright3,13, Tsung-Jung Wu12, Liewei Wang3,18, Richard M Weinshilboum3,18.   

Abstract

Mesh:

Year:  2020        PMID: 31378813      PMCID: PMC7124480          DOI: 10.1093/ije/dyz123

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


× No keyword cloud information.
  27 in total

1.  Using RxNorm and NDF-RT to classify medication data extracted from electronic health records: experiences from the Rochester Epidemiology Project.

Authors:  Jyotishman Pathak; Sean P Murphy; Brian N Willaert; Hilal M Kremers; Barbara P Yawn; Walter A Rocca; Christopher G Chute
Journal:  AMIA Annu Symp Proc       Date:  2011-10-22

2.  Clinical Decision Support to Implement CYP2D6 Drug-Gene Interaction.

Authors:  Pedro J Caraballo; Mark Parkulo; David Blair; Michelle Elliott; Cloann Schultz; Joseph Sutton; Padma Rao; Jamie Bruflat; Robert Bleimeyer; John Crooks; Donald Gabrielson; Wayne Nicholson; Carolyn Rohrer Vitek; Kelly Wix; Suzette J Bielinski; Jyotishman Pathak; Iftikhar Kullo
Journal:  Stud Health Technol Inform       Date:  2015

3.  Active computerized pharmacovigilance using natural language processing, statistics, and electronic health records: a feasibility study.

Authors:  Xiaoyan Wang; George Hripcsak; Marianthi Markatou; Carol Friedman
Journal:  J Am Med Inform Assoc       Date:  2009-03-04       Impact factor: 4.497

4.  Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol.

Authors:  Suzette J Bielinski; Janet E Olson; Jyotishman Pathak; Richard M Weinshilboum; Liewei Wang; Kelly J Lyke; Euijung Ryu; Paul V Targonski; Michael D Van Norstrand; Matthew A Hathcock; Paul Y Takahashi; Jennifer B McCormick; Kiley J Johnson; Karen J Maschke; Carolyn R Rohrer Vitek; Marissa S Ellingson; Eric D Wieben; Gianrico Farrugia; Jody A Morrisette; Keri J Kruckeberg; Jamie K Bruflat; Lisa M Peterson; Joseph H Blommel; Jennifer M Skierka; Matthew J Ferber; John L Black; Linnea M Baudhuin; Eric W Klee; Jason L Ross; Tamra L Veldhuizen; Cloann G Schultz; Pedro J Caraballo; Robert R Freimuth; Christopher G Chute; Iftikhar J Kullo
Journal:  Mayo Clin Proc       Date:  2014-01       Impact factor: 7.616

Review 5.  Genomics and drug response.

Authors:  Liewei Wang; Howard L McLeod; Richard M Weinshilboum
Journal:  N Engl J Med       Date:  2011-03-24       Impact factor: 91.245

6.  Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project.

Authors:  Jennifer L St Sauver; Brandon R Grossardt; Barbara P Yawn; L Joseph Melton; Walter A Rocca
Journal:  Am J Epidemiol       Date:  2011-03-23       Impact factor: 4.897

7.  Influence of the MedDRA hierarchy on pharmacovigilance data mining results.

Authors:  Ronald K Pearson; Manfred Hauben; David I Goldsmith; A Lawrence Gould; David Madigan; Donald J O'Hara; Stephanie J Reisinger; Alan M Hochberg
Journal:  Int J Med Inform       Date:  2009-02-18       Impact factor: 4.046

8.  Feasibility of pooling annotated corpora for clinical concept extraction.

Authors:  Kavishwar Wagholikar; Manabu Torii; Siddhartha Jonnalagadda; Hongfang Liu
Journal:  AMIA Jt Summits Transl Sci Proc       Date:  2012-03-19

9.  Increased risk of hospitalization for ultrarapid metabolizers of cytochrome P450 2D6.

Authors:  Paul Y Takahashi; Euijung Ryu; Jyotishman Pathak; Gregory D Jenkins; Anthony Batzler; Matthew A Hathcock; John Logan Black; Janet E Olson; James R Cerhan; Suzette J Bielinski
Journal:  Pharmgenomics Pers Med       Date:  2017-02-14

10.  CYP2D6 phenotypes are associated with adverse outcomes related to opioid medications.

Authors:  Jennifer L St Sauver; Janet E Olson; Veronique L Roger; Wayne T Nicholson; John L Black; Paul Y Takahashi; Pedro J Caraballo; Elizabeth J Bell; Debra J Jacobson; Nicholas B Larson; Suzette J Bielinski
Journal:  Pharmgenomics Pers Med       Date:  2017-07-24
View more
  18 in total

Review 1.  Clinical implementation of drug metabolizing gene-based therapeutic interventions worldwide.

Authors:  Evangelia Eirini Tsermpini; Zeina N Al-Mahayri; Bassam R Ali; George P Patrinos
Journal:  Hum Genet       Date:  2021-10-01       Impact factor: 4.132

2.  Concordance between predicted HLA type using next generation sequencing data generated for non-HLA purposes and clinical HLA type.

Authors:  Ann M Moyer; Brian Dukek; Patti Duellman; Brittany Schneider; Laurie Wakefield; Jennifer M Skierka; Rajeswari Avula; Aditya V Bhagwate; Krishna R Kalari; Justin D Kreuter; Matthew P Goetz; Judy C Boughey; John L Black; Manish J Gandhi
Journal:  Hum Immunol       Date:  2020-06-13       Impact factor: 2.850

3.  Sex differences in type and occurrence of adverse reactions to opioid analgesics: a retrospective cohort study.

Authors:  Guilherme S Lopes; Suzette Bielinski; Ann M Moyer; Debra J Jacobson; Liwei Wang; Ruoxiang Jiang; Nicholas B Larson; Virginia M Miller; Ye Zhu; Dana C Cavanaugh; Jennifer St Sauver
Journal:  BMJ Open       Date:  2021-06-30       Impact factor: 3.006

Review 4.  Pharmacogenomics education, research and clinical implementation in the state of Minnesota.

Authors:  Jeffrey R Bishop; R Stephanie Huang; Jacob T Brown; Pawel Mroz; Steven G Johnson; Josiah D Allen; Suzette J Bielinski; Julie England; Joel F Farley; David Gregornik; Jyothsna Giri; Christine Kroger; Susie E Long; Tiana Luczak; Erin J McGonagle; Sisi Ma; Eric T Matey; Pinar K Mandic; Ann M Moyer; Wayne T Nicholson; Natasha Petry; Pamala A Pawloski; Allyson Schlichte; Stephen W Schondelmeyer; Randall D Seifert; Marilyn K Speedie; David Stenehjem; Robert J Straka; Jason Wachtl; Stephen C Waring; Brian Van Ness; Heather A Zierhut; Constantin Aliferis; Susan M Wolf; Catherine A McCarty; Pamala A Jacobson
Journal:  Pharmacogenomics       Date:  2021-06-17       Impact factor: 2.638

5.  Implementation of preemptive DNA sequence-based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study.

Authors:  Liewei Wang; Steven E Scherer; Suzette J Bielinski; Donna M Muzny; Leila A Jones; John Logan Black; Ann M Moyer; Jyothsna Giri; Richard R Sharp; Eric T Matey; Jessica A Wright; Lance J Oyen; Wayne T Nicholson; Mathieu Wiepert; Terri Sullard; Timothy B Curry; Carolyn R Rohrer Vitek; Tammy M McAllister; Jennifer L St Sauver; Pedro J Caraballo; Konstantinos N Lazaridis; Eric Venner; Xiang Qin; Jianhong Hu; Christie L Kovar; Viktoriya Korchina; Kimberly Walker; HarshaVardhan Doddapaneni; Tsung-Jung Wu; Ritika Raj; Shawn Denson; Wen Liu; Gauthami Chandanavelli; Lan Zhang; Qiaoyan Wang; Divya Kalra; Mary Beth Karow; Kimberley J Harris; Hugues Sicotte; Sandra E Peterson; Amy E Barthel; Brenda E Moore; Jennifer M Skierka; Michelle L Kluge; Katrina E Kotzer; Karen Kloke; Jessica M Vander Pol; Heather Marker; Joseph A Sutton; Adrijana Kekic; Ashley Ebenhoh; Dennis M Bierle; Michael J Schuh; Christopher Grilli; Sara Erickson; Audrey Umbreit; Leah Ward; Sheena Crosby; Eric A Nelson; Sharon Levey; Michelle Elliott; Steve G Peters; Naveen Pereira; Mark Frye; Fadi Shamoun; Matthew P Goetz; Iftikhar J Kullo; Robert Wermers; Jan A Anderson; Christine M Formea; Razan M El Melik; John D Zeuli; Joseph R Herges; Carrie A Krieger; Robert W Hoel; Jodi L Taraba; Scott R St Thomas; Imad Absah; Matthew E Bernard; Stephanie R Fink; Andrea Gossard; Pamela L Grubbs; Therese M Jacobson; Paul Takahashi; Sharon C Zehe; Susan Buckles; Michelle Bumgardner; Colette Gallagher; Kelliann Fee-Schroeder; Nichole R Nicholas; Melody L Powers; Ahmed K Ragab; Darcy M Richardson; Anthony Stai; Jaymi Wilson; Joel E Pacyna; Janet E Olson; Erica J Sutton; Annika T Beck; Caroline Horrow; Krishna R Kalari; Nicholas B Larson; Hongfang Liu; Liwei Wang; Guilherme S Lopes; Bijan J Borah; Robert R Freimuth; Ye Zhu; Debra J Jacobson; Matthew A Hathcock; Sebastian M Armasu; Michaela E McGree; Ruoxiang Jiang; Tyler H Koep; Jason L Ross; Matthew G Hilden; Kathleen Bosse; Bronwyn Ramey; Isabelle Searcy; Eric Boerwinkle; Richard A Gibbs; Richard M Weinshilboum
Journal:  Genet Med       Date:  2022-03-21       Impact factor: 8.864

6.  Targeted Genotyping in Clinical Pharmacogenomics: What Is Missing?

Authors:  Jaime L Lopes; Kimberley Harris; Mary Beth Karow; Sandra E Peterson; Michelle L Kluge; Katrina E Kotzer; Guilherme S Lopes; Nicholas B Larson; Suzette J Bielinski; Steven E Scherer; Liewei Wang; Richard M Weinshilboum; John L Black; Ann M Moyer
Journal:  J Mol Diagn       Date:  2022-01-15       Impact factor: 5.341

7.  Comparing outcomes and costs among warfarin-sensitive patients versus warfarin-insensitive patients using The Right Drug, Right Dose, Right Time: Using genomic data to individualize treatment (RIGHT) 10K warfarin cohort.

Authors:  Kristi M Swanson; Ye Zhu; Ricardo L Rojas; Jennifer L St Sauver; Suzette J Bielinski; Debra J Jacobsen; Sue L Visscher; Liewei Wang; Richard Weinshilboum; Bijan J Borah
Journal:  PLoS One       Date:  2020-05-19       Impact factor: 3.240

Review 8.  Concepts Driving Pharmacogenomics Implementation Into Everyday Healthcare.

Authors:  Jyothsna Giri; Ann M Moyer; Suzette J Bielinski; Pedro J Caraballo
Journal:  Pharmgenomics Pers Med       Date:  2019-10-30

9.  Sex Differences in Associations Between CYP2D6 Phenotypes and Response to Opioid Analgesics.

Authors:  Guilherme S Lopes; Suzette J Bielinski; Ann M Moyer; John Logan Black Iii; Debra J Jacobson; Ruoxiang Jiang; Nicholas B Larson; Jennifer L St Sauver
Journal:  Pharmgenomics Pers Med       Date:  2020-03-13

10.  An assessment of patient perspectives on pharmacogenomics educational materials.

Authors:  Gladys B Asiedu; Lila J Finney Rutten; Amenah Agunwamba; Suzette J Bielinski; Jennifer L St Sauver; Janet E Olson; Carolyn R Rohrer Vitek
Journal:  Pharmacogenomics       Date:  2020-04-15       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.